Overview
Lipofibromatosis is a rare benign neoplasm characterized by the proliferation of adipose tissue and fibrous elements, with reported occurrences in cardiac locations leading to significant cardiac dysfunction and rhythm disturbances 1.Diagnosis
Imaging Techniques: Transthoracic echocardiography and cardiac magnetic resonance imaging are crucial for tissue characterization and diagnosis 1.
Clinical Presentation: Often associated with arrhythmias such as atrial fibrillation and conduction abnormalities like complete heart block 1.Management
Surgical Intervention: Likely required for definitive treatment, particularly in symptomatic cases or when there is significant impact on cardiac function 1.
Device Implantation: Permanent pacemaker may be necessary for managing conduction abnormalities 1.
Multimodal Monitoring: Continuous monitoring of cardiac function and rhythm post-diagnosis is essential 1.Special Populations
Elderly: Increased risk of complications from arrhythmias and the need for device implantation; careful management is crucial 1.Key Recommendations
Utilize multimodality imaging (echocardiography, MRI) for accurate diagnosis of cardiac lipofibromatosis (Evidence: Moderate 1).
Consider surgical resection for definitive treatment in symptomatic patients (Evidence: Expert opinion 1).
Implant a permanent pacemaker if there is evidence of complete heart block or significant conduction disturbances (Evidence: Expert opinion 1).References
1 Shen S, Rizkallah J, Kirkpatrick ID, Khadem A, Jassal DS. Cardiac lipofibromatosis. The Canadian journal of cardiology 2013. link